Kishan Mehta - 15 Jun 2021 Form 3 Insider Report for Biohaven Pharmaceutical Holding Co Ltd. (BHVN)

Role
Director
Signature
/s/ Jim Engelhart, Attorney-in-Fact
Issuer symbol
BHVN
Transactions as of
15 Jun 2021
Transactions value $
$0
Form type
3
Filing time
17 Jun 2021, 21:50:50 UTC
Next filing
12 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BHVN Common Shares 8.77K 15 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BHVN Stock Options (Right to buy) 15 Jun 2021 Common Shares 15K $52.13 Direct F1
holding BHVN Stock Options (Right to buy) 15 Jun 2021 Common Shares 20K $37.56 Direct F2
holding BHVN Restricted Share Unit Award 15 Jun 2021 Common Shares 3.75K Direct F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this stock option vest in four equal installments on December 18, 2019, 2020, 2021 and 2022, subject to the Reporting Person's continuous service with the Issuer through such vesting date.
F2 The options are fully vested.
F3 Each restricted share unit represents the contingent right to receive one common share of the Issuer.
F4 The reporting person was granted 7,500 restricted share units on January 8, 2020, vesting in four equal installments on January 8, 2020, 2021, 2022 and 2023, subject to the reporting person's continued service with the Issuer at each vesting date.
F5 Not applicable.

Remarks:

Exhibit 24.1 - Power of Attorney